Page last updated: 2024-08-21

indoline and Prostatic Neoplasms

indoline has been researched along with Prostatic Neoplasms in 3 studies

*Prostatic Neoplasms: Tumors or cancer of the PROSTATE. [MeSH]

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Candeias, NR; Kandhavelu, M; Le, HTT; Murugesan, A; Ramesh, T; Yli-Harja, O1
Dhayabaran, VV; Kumar, MR; Manikandan, A; Sivakumar, A1
Bian, J; Ge, R; Li, Z; Xie, Z; Xu, X; Zhang, Z; Zuo, M1

Other Studies

3 other study(ies) available for indoline and Prostatic Neoplasms

ArticleYear
P2Y1 agonist HIC in combination with androgen receptor inhibitor abiraterone acetate impairs cell growth of prostate cancer.
    Apoptosis : an international journal on programmed cell death, 2022, Volume: 27, Issue:3-4

    Topics: Abiraterone Acetate; Androgen Receptor Antagonists; Apoptosis; Cell Line, Tumor; Cell Proliferation; Humans; Indoles; Male; Prostatic Neoplasms; Purinergic P2Y Receptor Agonists; Receptors, Androgen; Receptors, Purinergic P2Y1

2022
An eco-friendly catalytic system for multicomponent, one-pot synthesis of novel spiro-chromeno indoline-triones and their anti-prostate cancer potentials evaluated via alkaline phosphatase inhibition mechanism.
    Bioorganic chemistry, 2018, Volume: 81

    Topics: Alkaline Phosphatase; Antineoplastic Agents; Catalysis; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Indoles; Male; Molecular Docking Simulation; Molecular Structure; Prostatic Neoplasms; Spiro Compounds; Structure-Activity Relationship

2018
Design and synthesis of indoline thiohydantoin derivatives based on enzalutamide as antiproliferative agents against prostate cancer.
    European journal of medicinal chemistry, 2017, Jan-05, Volume: 125

    Topics: Active Transport, Cell Nucleus; Antineoplastic Agents; Benzamides; Cell Line, Tumor; Cell Proliferation; Humans; Indoles; Male; Molecular Docking Simulation; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms; Receptors, Androgen; Thiohydantoins

2017